1-5 of 5
Jordan Gauthier, MD MSc
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

High IL-15 Serum Concentrations Are Associated with Response to CD19 CAR T-Cell Therapy and Robust In Vivo CAR T-Cell Kinetics

Jordan Gauthier, MD MSc, Cassie Chou, MDPhD, Alexandre V. Hirayama, MD, Salvatore Fiorenza, MBBS, PhD, Alyssa Sheih, PhD, Barbara S. Pender, MSc, Tinh-Doan Phi, BSc, Rachel Steinmetz, BSc, Abby Jamieson, BSc, Delaney R Kirchmeier, BSc, Henna N Di, BSc, Stanley R. Riddell, MD, David G. Maloney, MD PhD, Cameron J. Turtle, MBBS, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-140120
Published: 2020
Journal Articles

Third Generation CD20 Targeted CAR T-Cell Therapy (MB-106) for Treatment of Patients with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Mazyar Shadman, MDMPH, Cecilia Yeung, MD, Mary W Redman, PhD, Sang Yun Lee, PhD, Dong Hoon Lee, B.S., Ajeetha Ramachandran, PhD, Susan Ra, BS, Edmond A Marzbani, MD, Solomon A. Graf, MD, Edus H. Warren, MD PhD, Ajay K. Gopal, MD, Aude G. Chapuis, MD, Merav Bar, Damian J. Green, MD, Jordan Gauthier, MD MSc, Ryan D. Cassaday, MD, Hans-Peter Kiem, MD PhD, Cameron J. Turtle, MBBS, PhD, David G. Maloney, MD PhD, Brian G. Till, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 38–39.
https://doi.org/10.1182/blood-2020-136440
Published: 2020
Journal Articles

Factors Associated with Response, CAR-T Cell In Vivo Expansion, and Progression-Free Survival after Repeat Infusions of CD19 CAR-T Cells

Evandro D. Bezerra, MD, Jordan Gauthier, MD MSc, Alexandre V. Hirayama, MD, Barbara S. Pender, MSc, Reed M. Hawkins, BS, Aesha Vakil, MSc, Rachel N. Steinmetz, BS, Aude G. Chapuis, MD, Brian G. Till, MD, Hans-Peter Kiem, MD PhD, Mazyar Shadman, MD MPH, Ryan D. Cassaday, MD, Stanley R. Riddell, MD, David G. Maloney, MD PhD, Cameron J. Turtle, MBBS, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 201.
https://doi.org/10.1182/blood-2019-123807
Published: 2019
Journal Articles

Relapsed or Refractory CLL after CD19-Specific CAR-T Therapy: Treatment Patterns and Clinical Outcomes

Mazyar Shadman, MD, Jordan Gauthier, MD MSc, Sirin Khajavian, MD, Alexandre V. Hirayama, MD, Ryan C. Lynch, MD, Stephen D. Smith, MD, Chaitra S. Ujjani, MD, Victor A. Chow, MD, Hans-Peter Kiem, MD PhD, Brian G. Till, MD, Ajay K. Gopal, MD, David G. Maloney, MD PhD, Cameron J. Turtle, MBBS, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4294.
https://doi.org/10.1182/blood-2019-126269
Published: 2019
Journal Articles

Severe Cytokine Release Syndrome Is Associated with Impaired Hematopoietic Recovery after CD19-Targeted CAR-T Cell Therapy

Krishna R. Juluri, MD PhD, Alexandre V. Hirayama, MD, Erin Mullane, DNP, Nancy Cleary, BSc, Qian Vicky Wu, PhD, David G. Maloney, MD PhD, Cameron J. Turtle, MBBS, PhD, Merav Bar, MD, Jordan Gauthier, MD MSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 3229.
https://doi.org/10.1182/blood-2019-126922
Published: 2019